Does melatonin improve sleep in children with neurodevelopmental disorders?

Area of Science:

• Pediatric Neurology
• Sleep Medicine
• Pharmacology

Background:

• Sleep problems are common in children with neurodevelopmental disorders.
• These sleep disturbances significantly impact quality of life for affected children and their families.
• Current management strategies for pediatric sleep issues often have limitations.

Purpose of the Study:

• To systematically review and meta-analyze the efficacy of melatonin for managing sleep problems in children with neurodevelopmental disorders.
• To evaluate the impact of melatonin on sleep onset latency, duration, and overall sleep quality.
• To provide evidence-based guidance for clinicians managing sleep disturbances in this population.

Main Methods:

• Systematic literature search of relevant databases (e.g., PubMed, Embase, PsycINFO).
• Inclusion of randomized controlled trials and observational studies assessing melatonin use in children with neurodevelopmental disorders.
• Meta-analysis of quantitative data to determine effect sizes for various sleep parameters.

Main Results:

• Melatonin demonstrated a statistically significant improvement in sleep onset latency and total sleep time.
• A moderate effect size was observed for melatonin's efficacy in improving sleep quality.
• No significant adverse events were reported, suggesting a favorable safety profile.

Conclusions:

• Melatonin is a potentially effective and safe option for managing sleep problems in children with neurodevelopmental disorders.
• Further high-quality research is warranted to optimize dosing and long-term outcomes.
• Clinicians can consider melatonin as an adjunctive therapy for pediatric sleep disturbances.